Link 1
[ Printer-friendly page Printer-friendly page ]

NYU College of Dentistry First to Add Epocrates Drug and Disease References

SAN MATEO, Calif.ornia – Epocrates, Inc. announces analliance today with New York University College of Dentistry (NYUCD) toprovide students with the latest in mobile medical information. NYUCD, thelargest and third oldest dental school in the United States, is the firstdental school to incorporate Epocrates and the use of personal digitalassistants (PDAs) into its curriculum. The technology will enhance dentaleducation and help future dentists and hygienists fulfill their commitment toprovide the best in oral health care.

"PDAs provide critical educational and clinical value for our students andpatients by providing medical reference information at chairside," said EliseEisenberg, DDS, MS, director of dental informatics for NYUCD. "Epocratesprovides this information in an easy-to-use interface with frequent contentupdates and is already being used as a key application by many of ourfaculty."

NYUCD will implement a four-year PDA curriculum that will integrate theuse of handheld technology into didactic and clinical courses beginning withthe first course in dental school. This early integration of PDAs, whichfocuses on enhancing dental education and patient care, will carry over intoclinical practice and directly impact and enhance the quality of treatmentstudents are learning to provide.

"NYUCD is setting a precedent as the first dental education institution toembrace the mobile learning environment and to require PDAs for new students,"said Kirk Loevner, Epocrates chairman and CEO. "Whether in the classroom orexam room, students and faculty can now quickly access reliable and timelyinformation on medications, drug interactions and related topics."

The curriculum will stress the importance to students of understanding themedications their patients are taking. Having Epocrates products on their PDAsis an easy way for them to access this information quickly, look up drugs byname or class and identify potential drug-drug interactions or adverse sideeffects, according to Miriam Robbins, DDS, MS, clinical associate professorand associate chair of oral and maxillofacial pathology, radiology andmedicine at NYUCD.

In the three-year agreement, more than 1,000 dental and dental hygienestudents will receive Epocrates Rx Pro® drug and formulary reference andEpocrates Dx™ disease, diagnosis and treatment guide. Students will usethese resources for the duration of their program to reference more than 3,000drug monographs, check up to 30 drugs simultaneously for interactions, anddiscern more than 1,200 diseases and conditions. In addition, NYUCD facultywill use Epocrates® Essentials all-in-one mobile guide as well as haveaccess to Epocrates Rx Online® web-based drug reference on their desktops.

About New York University College of Dentistry

Founded in 1865, NYU College of Dentistry is the largest dental school andthe largest provider of comprehensive, affordable dental care in the U.S. NYUCollege of Dentistry has a significant global reach and provides a level ofnational and international diversity among its students that is unmatched byany other dental school. For more information, please visithttp://www.nyu.edu/dental.

About Epocrates, Inc.

San Mateo, CA-based Epocrates is transforming the practice of medicine byproviding innovative clinical tools at the point of care and deployingleading-edge technologies that enable communication. The company has built aclinical network connecting more than 1 in 4 U.S. physicians, students atevery U.S. medical school and hundreds of thousands of other allied healthcareprofessionals with other healthcare stakeholders. Epocrates' products haveshown a positive impact on patient safety, healthcare efficiency, and patientsatisfaction. For more information, please visit http://www.epocrates.com.

SOURCE: Epocrates, Inc.

[ Printer-friendly page Printer-friendly page ]
This site is intended for your general information only. Is not a substitute for medical advice or treatment.
Use of this site is subject to our Terms of Use.
Page created in 0.660228967667 seconds.